MedTrace Logo

Quercetin's Effect on Bone Health and Inflammatory Markers

NCT05371340 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2022-05-12

No results posted yet for this study

Summary

Quercetin is a plant-based flavonoid that is naturally found in many fruits and vegetables, and is considered to be a potent antioxidant with several expected health benefits such as anti-inflammatory effects and bone-conserving properties. Participants will supplement with either Quercetin, or placebo, for 90-days with pre- and post-testing visits.

Conditions

  • Osteoporosis, Postmenopausal

Interventions

DIETARY_SUPPLEMENT

Quercetin (500 mg)

Once-daily 500 mg Quercetin

OTHER

Placebo (500 mg)

Once-daily 500 mg methylcellulose 9E4M)

Sponsors & Collaborators

  • Kennesaw State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-27
Primary Completion
2020-04-27
Completion
2020-04-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05371340 on ClinicalTrials.gov